Biliary Stents Market Report 2025

The biliary stents market size has grown strongly in recent years. It will grow from $0.47 billion in 2024 to $0.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing prevalence of biliary diseases, the rising incidence of pancreatic and liver cancers, the growing geriatric population, the expanding use of minimally invasive procedures, and heightened awareness among patients and physicians.

The biliary stents market size is expected to see strong growth in the next few years. It will grow to $0.63 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to the rising demand for personalized and precision medicine, growing adoption of biodegradable stents, increasing focus on outpatient and ambulatory care settings, expansion of medical tourism in developing countries, increasing prevalence of lifestyle-related liver disorders, and rising healthcare investments in emerging economies. Key trends expected during the forecast period include the integration of drug-eluting technologies, advancements in self-expanding stent materials, the use of 3D printing for customized stents, miniaturization of stent delivery systems, incorporation of radiopaque markers for enhanced imaging, and the application of nanotechnology in stent coatings.

The rising incidence of pancreatic cancer is expected to propel the growth of the biliary stents market going forward. Pancreatic cancer is a type of cancer that originates in the tissues of the pancreas, an organ crucial for digestion and blood sugar regulation. The incidence of pancreatic cancer is increasing due to an aging population and the growing prevalence of risk factors such as obesity, diabetes, and smoking. Biliary stents aid pancreatic cancer care by relieving bile duct obstructions, improving liver function, and reducing jaundice. They enhance patient comfort by promoting bile flow, supporting ongoing cancer treatment, and improving quality of life. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising incidence of pancreatic cancer is driving the growth of the biliary stents market.

Major companies operating in the biliary stents market are focusing on developing advanced products, such as drug-eluting stents, to improve patient outcomes, increase durability, and reduce complications like restenosis. Drug-eluting stents are specialized biliary stents coated with medication that is slowly released to prevent tissue overgrowth and blockages in the bile ducts. For instance, in July 2024, CGBIO, a South Korea-based medical device company, received Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for biliary ARISTENT. This stent is designed to treat bile duct blockages and features a patented ‘HOOK & CROSS’ structure for enhanced flexibility and long-term patency. It adapts to the bile duct’s anatomy, reducing migration risk and improving patient comfort, while its advanced drug-eluting coating minimizes inflammation and prolongs stent patency, offering an effective solution for biliary obstructions.

In January 2024, Olympus Corporation, a Japan-based medical technology company, acquired Taewoong Medical Co. Ltd. for \$370 million. Through this acquisition, Olympus aims to strengthen its global endoscopic device portfolio by incorporating Taewoong’s metallic stents, including biliary stents, enhancing its capabilities in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a South Korea-based company specializing in self-expandable metallic stents, including biliary stents.

Major players in the biliary stents market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton, Dickinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, M.I Tech.

North America was the largest region in the biliary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biliary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biliary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Biliary stents are small, tube-like devices inserted into the bile ducts to maintain their openness and ensure proper bile flow from the liver to the intestines. They are commonly used to relieve blockages caused by conditions such as tumors, gallstones, or inflammation. Biliary stents help prevent or reduce bile duct obstruction, alleviating symptoms like jaundice and minimizing the risk of liver damage.

The key types of biliary stents include metal, polymer, and plastic stents. Metal stents are tubular devices made from alloys such as stainless steel, nitinol (nickel-titanium), cobalt-chromium, and platinum-chromium. They are available in different designs, including single, double, and triple stents, and are used in procedures like endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. These stents are applied in managing biliopancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and other conditions, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The biliary stents market research report is one of a series of new reports that provides biliary stents market statistics, including the biliary stents industry global market size, regional shares, competitors with the biliary stents market share, detailed biliary stents market segments, market trends, and opportunities, and any further data you may need to thrive in the Biliary stents industry. This biliary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biliary stents market consists of sales of biliary stent systems, single-use and reusable devices, bioabsorbable stents, and stent delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.